FDA Inspection 1084371 — Abbott Laboratories

Abbott Laboratories — FEI 1415939

The FDA completed an inspection of Abbott Laboratories on March 29, 2019 in Abbott Park, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 29, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Abbott Park, IL (United States)

Citations

IDCFRDescription
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
311521 CFR 820.70(h)Use and removal, Lack of or inadequate procedures